Stocks & ETFunds

When it comes to valuing stocks, the price-to-earnings (P/E) ratio is the number one metric for investors that want an instant fix on what the market thinks of a company. [That being said]...there are health warnings to heed if you don’t want to be left exposed by its limitations. [Let me explain.] Words: 1101

The number, market cap and currencies of the constituents of the HUI, XAU, GDX, XGD and CDNX indices differ considerably from each other and, as such, each index presents a different picture of what is really happening in the precious metals marketplace. This article analyzes the make-up of each index to reveal the biases of each to arrive at the answer to the question in the title. Words: 1026

Remember, the trend is your friend and now you have an arsenal of such indicators to make an extensive and in-depth assessment of whether you should be buying or selling. If ever there was a “cut and save” investment advisory this article is it. Words: 1579

If history repeats, so many will look back at this day and say, “Why, oh why, did I not listen to Goldrunner? Silver at $14.98 is about as good a time as it gets. IT’S LAST CALL AT THE BAR………..THE SILVER BAR.

The number, market cap and currencies of the constituents of the HUI, XAU, GDX, XGD and CDNX indices differ considerably from each other and, as such, each index presents a different picture of what is really happening in the precious metals marketplace. This article analyzes the make-up of each index to reveal the biases of each to arrive at the answer to the question in the title. Words: 1026

Aurora Cannabis Inc. (NYSE: ACB; TSX: ACB) yesterday announced its financial and operational results for the fourth quarter and fiscal year ended June 30, 2019.

It's hard to know what to buy or sell let alone just when to prudently do so. Thank goodness there are indicators available that provide information of stock and index movement of a more immediate nature to help you make such important decisions. This article describes the 6 most popular Momentum Indicators.

As evidence of cannabis’ many benefits mounts, so does the interest from the global pharmaceutical industry, known as Big Pharma. The entrance of such behemoths will radically transform the cannabis industry. Today’s infographic comes to us from CB2 Insights, and explores how and why the notorious Big Pharma are interested in the nascent cannabis industry.

Curaleaf's strategy is to become the leading vertically integrated multi-state cannabis operator in the United States and they are well on their way to achieving that goal.

Origin House (CSE: OH, OTCQX: ORHOF), a North American cannabis products and brands company, has announced its financial results for Q2 that ended June 30, 2019.